Additional booster doses in patients with chronic lymphocytic leukemia induce humoral and cellular immune responses to SARS-CoV-2 similar to natural infection regardless ongoing treatments: A study by ERIC, the European Research Initiative on CLL Am J Hematol
e14a2 Transcript Favors Treatment-Free Remission in Chronic Myeloid Leukemia When Associated with Longer Treatment with Tyrosine Kinase Inhibitors and Sustained Deep Molecular Response J Clin Med
Chromosomal instability in aneuploid acute lymphoblastic leukemia associates with disease progression EMBO Mol Med
Outcome improvement over time in reduced intensity conditioning hematopoietic transplantation: a 20-year experience Ann Hematol